Using a randomized crossover trial design , in a pilot study we compared 14 days of IV tobramycin with nebulized tobramycin 300mg twice a day ( TNS ) in acute respiratory exacerbations in 20 CF adults chronically infected with Pseudomonas aeruginosa ( Psa ) .